Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Duodenoscope Infection Warnings Could Have Been Issued Earlier, FDA Reviewers Say May 6, 2015 Irvin Jackson Add Your Comments Federal investigators indicate that the FDA knew about the risk of problems with duodenoscopes as early as the Fall of 2013, when outbreaks of treatment-resistant bacteria were linked to problems with the cleaning specifications provided for the endoscopic devices. However, the agency did not issue warnings until this year, after several deaths among patients at UCLA Medical Center. The findings were outlined in a report filed by FDA reviewers ahead of a May 14-15 meeting of the agency’s Gastroenterology-Urology Devices advisory committee, which was scheduled in response to a series of recent duodenoscope infections among patients who underwent an endoscopic retrograde cholangiopancreatography (ERCP) procedure. According to the report’s executive summary (PDF), released on May 5, the FDA was first warned in late 2013 that the devices may spread infections even after being cleaned in accordance with instructions provided by the manufacturers. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The first public warnings about the issue were not released until concerns arose earlier this year over the reprocessing of duodenoscopes after an outbreak of deadly carbapenem-resistant enterobacteriaceae (CRE) infections at UCLA Ronald Reagan Medical Center. The hospital reported that two patients had died and several had been sickened by the antibiotic-resistant infections, and sent warning letters to 180 patients that could have been exposed. Shortly after, other hospitals announced they had tracked infections back to duodenoscopes as well, particularly those manufactured by Olympus. However, the FDA appears to have already known there was a problem. “The Centers for Disease Control and Prevention (CDC) alerted the FDA to a potential association of multi-drug resistant bacteria and duodenoscopes,” according to the report. “Upon further investigation, FDA learned that these new cases of infection were occurring despite confirmation that the users were following proper manufacturer cleaning and disinfection or sterilization instructions. FDA communicated with federal partners, manufacturers, and other stakeholders to better understand the critical factors contributing to these infections and how to best mitigate them.” The report indicates that, and a review into the history of duodenoscope approval within the FDA’s 510(k) fast track approval process, all took place in the fall of 2013 and the winter of 2014. Later in 2014, the FDA even began working with the CDC and the U.S. Environmental Protection Agency (EPA), identifying all High Level Disinfectant (HLD) manufacturers and developing testing methods and protocols for their analysis. The FDA did not issue a safety communication on duodenoscope cleaning problems until February 19 of this year. Duodenoscopes are flexible, lit tubes that are inserted down the throat to the top of the small intestines for gastrointestinal procedures. They allow contrast dye to be injected and can be used with other medical instruments to retrieve biopsy samples. The FDA estimates that more than 500,000 ERCP duodenoscope procedures occur each year in the U.S. The FDA warned that the design of the devices, which includes a movable “elevator” at the tip, may trap pathogens and blood even when recommended cleaning techniques are used. When the safety communication was issued, the FDA revealed that from January 2013 through December 2014, it received 75 reports of infections that affected about 135 patients linked to the use of the devices. However, the problems may go back even further. In 2009, the FDA issued an advisory to health care professionals following an infection outbreak that affected 16 patients in France following duodenoscope procedures. In 2012, duodenoscope use was linked to an outbreak at the Moffitt Cancer Center in Tampa, Florida, where four patients were infected with drug-resistant pathogens. The advisory meeting’s goal is to have health care experts discuss the effectiveness of cleaning, high level disinfection and sterilization methods for duodenoscopes. The panel will also discuss how much premarket information the FDA needs to ensure that the cleaning instructions are adequate before approving future duodenoscopes, best practices and guidelines for cleaning, known as reprocessing, and whether other risk mitigation efforts, like surveillance cultures, will be necessary. The advisory committee’s findings are not binding on the FDA, but the agency often weighs its’ advisors recommendations heavily before finalizing new rules and regulations. Olympus Duodenoscope Infection Lawsuits Several of the major outbreaks have been linked to duodenoscopes made by Olympus and used during ERCP procedures. A number of hospital infection lawsuits have been filed against Olympus in recent weeks by either former patients who were infected after ERCPs or by the family members of patients who died due to ERCP duodenoscope infections. The lawsuits accuse Olympus of negligence in failing to provide adequate cleaning instructions to hospitals, or failing to properly design its duodenoscopes. In late March, the FDA announced that Olympus had successfully validated new reprocessing instructions for some of its duodenoscopes. The new reprocessing instructions focus on the Olympus TJF-Q180V duodenoscope, which has been linked to at least two outbreaks. The FDA approved the new validation instructions despite the device not being properly approved for use. The new instructions involve raising and lowering the elevator for the duodenoscopes several times while immersing them during precleaning and significant increases in the amount of manual brushing, flushing procedures, flushing volume and other measures. The company is also sending out a new brush for cleaning the elevator recess area. The FDA is recommending that hospitals put the new cleaning instructions into use immediately and to train the appropriate staff on the proper cleaning of the duodenoscopes as soon as possible. Tags: Duodenoscope, Endoscope, ERCP, Hospital Infection, Infection, Olympus More Lawsuit Stories Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study July 11, 2025 Cancer-Causing PFAS Water Contamination in 98% of Tested Sites in U.S.: Report July 11, 2025 Lawsuit Alleges Risperdal, Zyprexa Caused Breast Cancer Diagnosis July 11, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025) Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)